Transurethral plasmakinetic enucleation of prostate for treating high-risk huge benign prostate hyperplasia

VernacularTitle:经尿道前列腺等离子剜除术治疗高危超大前列腺增生
Author: Honglin CHENG ; Chuang GUO ; Xuming LI ; Zongyong CHENG ; Feng LI ; Li ZHANG ; Qingsong WANG
Keywords: high-risk; prostate hyperplasia; transurethral plasmakinetic enucleation of prostate
From: Chongqing Medicine 2017;46(9):1201-1202,1205
CountryChina
Language:Chinese
Abstract: Objective To research the clinical effect of transurethral plasmakinetic enucleation of prostate (PKEP) in the treatment of high-risk huge benign prostate hyperplasia(BPH).Methods Fifty-two cases of high-risk huge(＞120 g) BPH in this hospita1 from May 2010 to May 2015 were selected and performed PKEP.International prostate symptoms score(IPSS),quality of life(QOL) score,residual urine(RUV) and biggest urine flow rate(Qmax) were observed after operation.Results The mean operation time was (130.12 ± 12.14) min,the mean intraroperation bleeding amount was (120.24±9.81) mL,the mean hospital stay was (14.52 ± 1.82)d,the mean weight of resected prostate tissues was (113.42 ± 12.53)g.Follow-up lasted for 6 months without serious complications.IPSS、QOL,RUV and Qmax after operation were improved obviously,the difference was statistically significant compared with before operation(P＜0.05).Conclusion PKEP is safe and effective in the treatment of high-risk huge BPH.